Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a breakthrough in cancer research. They have developed nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumours. This way of injecting medication ensures the optimal targeting of a tumour and avoids jeopardising the ...